AI Article Synopsis

Article Abstract

Evidence is presented which suggests that certain key markers of lepra bacilli reside collectively in Proprionibacterium acnes, Corynebacterium tuberculostearicum and Mycobacterium leprae. The unrestricted replication of Mycobacterium leprae depends most probably upon the presence of an immune-deficiency-inducing viral agent or possibly on the combined effects of the organisms considered.

Download full-text PDF

Source

Publication Analysis

Top Keywords

lepra bacilli
8
mycobacterium leprae
8
propionibacterium corynebacterium
4
corynebacterium mycobacterium
4
mycobacterium lepra
4
bacilli evidence
4
evidence presented
4
presented suggests
4
suggests key
4
key markers
4

Similar Publications

Background: Leprosy (Hansen's disease) is an infectious disease most common in resource-limited countries caused by the acid-fast bacilli Mycobacterium leprae and Mycobacterium lepromatosis that frequently affects the skin and peripheral nerves. Prompt diagnosis and treatment with multidrug therapy is crucial to reduce disease transmission and sequelae, which include nerve function impairment, ocular injury, and stigmatizing physical deformities. Traditional treatment of multibacillary leprosy consists of 12-24 months of multidrug therapy with dapsone, rifampin, and clofazimine.

View Article and Find Full Text PDF

Leprosy with subsequent type 2 reaction masquerading as cutaneous tuberculosis: a case report and diagnostic pitfalls in a non-endemic area.

Infez Med

December 2024

Infectious Disease Division, Department of Internal Medicine, Faculty of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, & King Fahad hospital of the University, Al-Khobar, Saudi Arabia.

Leprosy, a chronic infectious disease caused by complex, remains a significant global health concern despite being curable with multidrug therapy. Delayed diagnosis is common, particularly in non-endemic regions or when presenting with atypical symptoms. This can lead to missed opportunities for early intervention, potential disabilities, and increased transmission.

View Article and Find Full Text PDF

Background & objectives Although multi-drug therapy has decreased the burden of disease, leprosy is yet to be eliminated. Accelerating progress requires optimal use of existing tools, advanced diagnostic tests, newer drugs, and vaccines. The search for a vaccine with therapeutic and preventive potential is ongoing, but evidence on effectiveness and safety is lacking.

View Article and Find Full Text PDF
Article Synopsis
  • A significant portion of the genome of studied strains has become pseudogenes, but their genetic similarity remains high, with over 99% identity among isolates globally.
  • The research focused on comparing three strains of a pathogen, including a reference strain and two from Brazilian leprosy relapse patients, highlighting differences in genotype and interaction with human cells.
  • Despite minimal genetic differences, the strains displayed notable phenotypic changes, impacting their growth and interaction with host cells, which could enhance understanding of leprosy's varied clinical outcomes.
View Article and Find Full Text PDF

Background and objective Hansen's disease, also known as leprosy, is a chronic granulomatous condition caused by , primarily affecting the skin and peripheral nerves. The disease has a wide spectrum of clinical and histopathological manifestations, often mimicking other inflammatory and infectious conditions. This variability poses significant challenges in its early diagnosis and management.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!